Persons over the age of 65 have a higher risk for severe influenza-related complications and have the highest risk of mortality from influenza. Vaccination of older persons have traditionally been the main focus of influenza vaccine policy, and while vaccines are not as efficient in this population as in younger adults, it still remains the most effective public health tool to protect against influenza (WHO 2012). Vaccination recommendations vary slightly between countries in Europe, however almost all cover older people as a specific target group (Endrich et al 2009).
The debate on how to address the spread of incorrect information about vaccines and science in general, as never before, is affecting the main stakeholders in health and scientific communication.
Current vaccination campaigns aimed to address vaccine hesitancy do not work or do not work enough.
ASSET is close to its conclusion and a concluding conference will be held in Rome, on October 30-31, to present all the main outcomes of the project. This event will take place at the hotel NH Roma Leonardo Da Vinci and will be targeted to a selected audience of EU stakeholders and policy makers. It is conceived as a mobilization and mutual learning event at local, national and international levels on Science in Society related issues in epidemics and pandemics.
Karafillakis E, Larson HJ; ADVANCE consortium. Vaccine. 2017 Jul 28.
Objectives:
The success of vaccination strategies depends in part on population perceptions of benefits and risks of vaccines and related confidence in vaccination. Better knowledge of public concerns about vaccines and what is driving them is needed to inform vaccination strategies and communications. This literature reviewer examined studies on vaccine and vaccination risk perceptions and concerns across European populations.